Mother Appeals for UK Action as Son's Medical Cannabis Supplier Closes
· GlobeWire Daily World Desk · Source: www.bbc.co.uk

Image: BBC News · Photo source · Resized and letterboxed to 16:9; no AI generation
Joanne, a mother from Preston, UK, has stated that her 17-year-old son, Ben, has five weeks of medical cannabis medication left and faces critical health risks as the Dutch pharmacy dispensing his prescriptions is set to close on 1 December. Published on 20 November 2026, the report highlights the family's urgent appeal to the UK government for intervention.
Background on Ben's Treatment
Ben has severe drug-resistant epilepsy. According to his family, he has been prescribed medicinal cannabis in the form of Bedrolite and Bedica oils for the past seven years. His family reported that the treatment resulted in a sustained reduction of more than 90% in seizures, including seizure-free days, compared to a previous interruption when 194 seizures were recorded in 18 hours. Ben's neurologist has reportedly recommended no changes to his medication.
Supplier Bankruptcy and Campaign Demands
The Dutch company Bedrocan was declared bankrupt in October, prompting concerns over ongoing supplies. Joanne, who is a director of the medicinal cannabis campaign End Our Pain, demonstrated at Westminster to call for immediate action. The campaign's key demands include:
- Urgent UK government intervention with Dutch ministers to secure the immediate release and export of the original Dutch plant material needed by a ready UK manufacturer.
- Emergency legislative action to allow continued production and supply during Bedrocan's restructuring.
Government Responses
A spokesperson for the Department of Health and Social Care stated that the government has been working intensively on the issue through direct talks with suppliers and the Dutch government. The department expressed belief that sufficient stock exists to maintain supplies in the coming months while a long-term solution is pursued, and that officials are exploring ways to secure additional short-term supplies.
AI-assisted reporting; source claims are attributed and have not been independently verified.



